Precision Labs, LLC

Precision Labs, LLC was paid $4.91M by Medicaid between Jan 2018 and Dec 2024, across 55 billing codes. Its largest line is G0482, Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed — 42% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Ohio

Rank by total paid#23 of 116

Median peer was paid$313K

This provider vs. median16×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	43,962	$287K
2019	134,019	$911K
2020	328,152	$1.45M
2021	27,692	$576K
2022	15,354	$645K
2023	9,353	$672K
2024incomplete	4,943	$375K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed	42%	39,895	16,598	$2.07M
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	8.6%	6,694	3,143	$420K
80364		4.8%	56,762	5,182	$235K
80361		3.8%	39,157	5,102	$189K
80336		3.4%	36,560	4,369	$166K
80321		2.4%	20,227	5,269	$116K
80355		2.3%	11,247	5,275	$111K
80375		2.2%	11,002	5,214	$109K
80347		2.0%	9,836	4,645	$100K
80342		1.8%	11,312	5,274	$90K
80299		1.7%	15,168	5,078	$85K
80373		1.7%	19,847	5,078	$83K

43 more codes

80365		1.7%	19,847	$82K
83992		1.6%	11,153	$76K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	1.5%	2,856	$74K
80359		1.4%	10,985	$71K
80366		1.4%	10,986	$71K
80345		1.3%	18,126	$66K
80368		1.3%	11,242	$65K
80356		1.3%	10,624	$65K
80349		1.3%	11,190	$64K
80354		1.3%	10,804	$64K
80353		1.3%	10,918	$62K
80358		1.2%	10,777	$60K
80348		1.2%	11,052	$58K
80326		1.1%	10,923	$54K
80370		1.0%	9,359	$51K
80360		<1%	9,359	$47K
80369		<1%	20,590	$25K
80346		<1%	17,675	$24K
80363		<1%	37,264	$22K
82570		<1%	14,159	$13K
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	<1%	257	$5K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	377	$3K
80324		<1%	10,293	$3K
80362		<1%	1,467	$3K
86803		<1%	404	$2K
86708		<1%	395	$2K
86704		<1%	404	$2K
80053	Comprehensive metabolic panel	<1%	435	$2K
86706		<1%	405	$2K
84443	Thyroid stimulating hormone (TSH)	<1%	188	$2K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	362	$965.99
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	55	$801.24
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	54	$484.07
80061	Lipid panel	<1%	82	$428.20
85027		<1%	96	$378.50
83690		<1%	162	$344.29
82150		<1%	161	$325.78
83735		<1%	64	$213.82
36415	Collection of venous blood by venipuncture	<1%	126	$174.70
80178		<1%	50	$75.69
84439		<1%	16	$47.45
83036	Hemoglobin; glycosylated (A1C)	<1%	13	$37.77
84436		<1%	13	$7.38

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMOORE, SEAN (CEO)